View in EDS

Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.

Saved in:
Bibliographic Details
Title: Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Authors: Fedoriw A; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Shi L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., O'Brien S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Smitheman KN; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Wang Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hou J; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Sherk C; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Rajapurkar S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Laraio J; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Williams LJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Xu C; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng Q; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Bedford MT; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Barbash O; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Kruger RG; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mohammad HP; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Peng W; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Source: Cancer immunology research [Cancer Immunol Res] 2022 Apr 01; Vol. 10 (4), pp. 420-436.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35181787
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fedoriw+A%22">Fedoriw A</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Shi+L%22">Shi L</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22O'Brien+S%22">O'Brien S</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Smitheman+KN%22">Smitheman KN</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hou+J%22">Hou J</searchLink>; Department of Biology and Biochemistry, University of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Sherk+C%22">Sherk C</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Rajapurkar+S%22">Rajapurkar S</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Laraio+J%22">Laraio J</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Williams+LJ%22">Williams LJ</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Department of Biology and Biochemistry, University of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Han+G%22">Han G</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Feng+Q%22">Feng Q</searchLink>; Department of Biology and Biochemistry, University of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Bedford+MT%22">Bedford MT</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Barbash+O%22">Barbash O</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Kruger+RG%22">Kruger RG</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hwu+P%22">Hwu P</searchLink>; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Mohammad+HP%22">Mohammad HP</searchLink>; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Peng+W%22">Peng W</searchLink>; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101614637%22">Cancer immunology research</searchLink> [Cancer Immunol Res] 2022 Apr 01; Vol. 10 (4), pp. 420-436.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101614637 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2326-6074 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223266066%22">23266066 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35181787
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2326-6066.CIR-21-0614
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 420
    Titles:
      – TitleFull: Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fedoriw A
      – PersonEntity:
          Name:
            NameFull: Shi L
      – PersonEntity:
          Name:
            NameFull: O'Brien S
      – PersonEntity:
          Name:
            NameFull: Smitheman KN
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Hou J
      – PersonEntity:
          Name:
            NameFull: Sherk C
      – PersonEntity:
          Name:
            NameFull: Rajapurkar S
      – PersonEntity:
          Name:
            NameFull: Laraio J
      – PersonEntity:
          Name:
            NameFull: Williams LJ
      – PersonEntity:
          Name:
            NameFull: Xu C
      – PersonEntity:
          Name:
            NameFull: Han G
      – PersonEntity:
          Name:
            NameFull: Feng Q
      – PersonEntity:
          Name:
            NameFull: Bedford MT
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Barbash O
      – PersonEntity:
          Name:
            NameFull: Kruger RG
      – PersonEntity:
          Name:
            NameFull: Hwu P
      – PersonEntity:
          Name:
            NameFull: Mohammad HP
      – PersonEntity:
          Name:
            NameFull: Peng W
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2326-6074
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer immunology research
              Type: main
ResultId 1